147 related articles for article (PubMed ID: 37259447)
1. Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer.
He Y; Le X; Hu G; Li Q; Chen Z
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259447
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin.
Huang P; Le X; Huang F; Yang J; Yang H; Ma J; Hu G; Li Q; Chen Z
J Med Chem; 2020 May; 63(9):4685-4700. PubMed ID: 32290657
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors.
Bhuniya R; Yuan X; Bai L; Howie KL; Wang R; Li W; Park F; Yang CY
ACS Med Chem Lett; 2022 Feb; 13(2):188-195. PubMed ID: 35178174
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancer.
Zhao SF; Leng JF; Xie SS; Zhu LQ; Zhang MY; Kong LY; Yin Y
Eur J Med Chem; 2024 Mar; 268():116204. PubMed ID: 38364716
[TBL] [Abstract][Full Text] [Related]
5. Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells.
Gao Y; Zhang B; Wang Y; Shang G
Oncol Rep; 2018 Aug; 40(2):841-848. PubMed ID: 29901174
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical mitotic exit induced by a small molecule inhibitor of APC/C
Richeson KV; Bodrug T; Sackton KL; Yamaguchi M; Paulo JA; Gygi SP; Schulman BA; Brown NG; King RW
Nat Chem Biol; 2020 May; 16(5):546-555. PubMed ID: 32152539
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
8. p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma.
Chen Y; Yang P; Wang J; Gao S; Xiao S; Zhang W; Zhu M; Wang Y; Ke X; Jing H
Exp Hematol Oncol; 2023 Mar; 12(1):28. PubMed ID: 36882855
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
[TBL] [Abstract][Full Text] [Related]
10. CDC20 inhibitor Apcin inhibits embryo implantation in vivo and in vitro.
Guo C; Kong F; Lv Y; Gao N; Xiu X; Sun X
Cell Biochem Funct; 2020 Aug; 38(6):810-816. PubMed ID: 32458533
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin.
Gao Y; Guo C; Fu S; Cheng Y; Song C
Neoplasma; 2021 Mar; 68(2):382-390. PubMed ID: 33118830
[TBL] [Abstract][Full Text] [Related]
12. Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide.
Ding Y; Zhang C; He L; Song X; Zheng C; Pan Y; Yu S
Bioengineered; 2021 Dec; 12(2):10791-10798. PubMed ID: 34753395
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors.
Alanazi MM; Aldawas S; Alsaif NA
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678593
[TBL] [Abstract][Full Text] [Related]
15. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
17. Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.
Salem MG; El-Maaty DMA; El-Deen YIM; Elesawy BH; Askary AE; Saleh A; Saied EM; Behery ME
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956848
[TBL] [Abstract][Full Text] [Related]
18. Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.
Sackton KL; Dimova N; Zeng X; Tian W; Zhang M; Sackton TB; Meaders J; Pfaff KL; Sigoillot F; Yu H; Luo X; King RW
Nature; 2014 Oct; 514(7524):646-9. PubMed ID: 25156254
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
20. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
